Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Treatment by Dora Wiederhold
Introduction
Dora Wiederhold is a prominent inventor based in Houston, TX (US), known for her groundbreaking work in cancer treatment. With a focus on tumor suppressor gene therapy, her innovative approaches aim to enhance the efficacy of cancer therapies.
Latest Patents
Wiederhold holds a patent titled "Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer." This patent outlines methods and compositions for treating cancer by administering an effective amount of at least one CD122/CD132 agonist, an immune checkpoint inhibitor, and a viral composition engineered to overexpress a tumor suppressor gene. The patent also describes methods for enhancing anti-tumor efficacy by combining these agents with other cancer therapies. Notably, her treatments have shown remarkable results in highly aggressive forms of cancer, leading to complete tumor remissions and curative outcomes.
Career Highlights
Wiederhold's career is marked by her dedication to advancing cancer treatment methodologies. Her innovative research has contributed significantly to the field, particularly in developing therapies that address the challenges posed by resistant cancer types.
Collaborations
Wiederhold collaborates with Kerstin B Menander, a fellow researcher, to further explore and develop effective cancer treatment strategies. Their partnership exemplifies the collaborative spirit in the scientific community aimed at combating cancer.
Conclusion
Dora Wiederhold's contributions to cancer treatment through her innovative patent and collaborative efforts highlight her commitment to improving patient outcomes. Her work continues to inspire advancements in the field of oncology.